2018
DOI: 10.1177/0269215518800832
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of the HiBalance training program for elderly with Parkinson’s disease: analysis of data from a randomized controlled trial

Abstract: Objective: To determine the cost-effectiveness of the HiBalance training program for managing Parkinson's disease (PD)-related balance and gait disorders. Design: Cost comparison design following the randomized controlled trial comparing a novel balance training intervention with care as usual. Subjects: A total of 100 participants with mild-moderate PD were randomized to either the intervention (n = 51) or the control group (n = 49). Intervention: A 10-week (three times per week), group-based, progressive bal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 29 publications
0
16
0
Order By: Relevance
“…One study published cost-effectiveness data, 127 noting that balance intervention provided in a group setting was more costly than the usual care control group but yielded greater gains in balance, gait, and quality-adjusted life years for individuals with PD.…”
Section: Balance Training ♦♦♦♦mentioning
confidence: 99%
“…One study published cost-effectiveness data, 127 noting that balance intervention provided in a group setting was more costly than the usual care control group but yielded greater gains in balance, gait, and quality-adjusted life years for individuals with PD.…”
Section: Balance Training ♦♦♦♦mentioning
confidence: 99%
“…This reflects direct and indirect expenses considered startup activities, including intervention development and piloting, which have not been reported by existing boxing training studies. The cost is higher than a previous study 23 of a 10‐week balance program for people with PD that estimated the cost per participant to be $2490. This did not consider startup activities, including intervention development and piloting, as part of expenses.…”
Section: Discussionmentioning
confidence: 68%
“…It is important to evaluate the economics of our smart systems. Cost-effectiveness21 is used to assess how much it costs that intelligent systems and doctors to diagnose each gait disorder. To evaluate the cost-effectiveness from the healthcare system and the societal perspectives, we will collect the data of unit costs and utilisations of the equipment, medications and labour hours taken to deliver each individual diagnosis, as well as the additional cost of patients’ accommodations, transportation and productivity losses due to their disease.…”
Section: Methods and Analysismentioning
confidence: 99%
“…The secondary outcomes are as follows: (1) the specificity and the Youden index22 (calculate as sensitivity plus specificity minus one) of the intelligent system and clinicians to screen for gait disorders; (2) the positive and negative predictive values of the intelligent system and clinicians at different levels to screen for gait disorders and (3) healthcare costs of intelligent systems and clinicians to screen for gait disorders, and the incremental cost effectiveness ratio21 will be estimated by cost per additional true case detected using an intelligent system vs clinicians.…”
Section: Assessmentsmentioning
confidence: 99%